An ependymoma subtype is driven by fusion proteins related to the transcriptional regulator YAP1. Research now shows that localization of these fusion proteins within nuclear condensates is necessary and sufficient for tumour formation through the activation of various genetic and epigenetic oncogenic mechanisms.
This is a preview of subscription content, log in via an institution to check access.
References
Hu, X. et al. Nat. Cell Biol., https://doi.org/10.1038/s41556-022-01069-6 (2023).
Saleh, A. H. et al. Nat. Rev. Cancer 22, 208–222 (2022).
Taylor, M. D. et al. Cancer Cell 8, 323–335 (2005).
Andreiuolo, F. et al. Brain Pathol. 29, 205–216 (2019).
Pajtler, K. W. et al. Cancer Cell 27, 728–743 (2015).
Totaro, A. et al. Nat. Cell Biol. 20, 888–899 (2018).
Johnson, R. & Halder, G. Nat. Rev. Drug Discov. 13, 63–79 (2014).
Eder, N. et al. Nat. Commun. 11, 2380 (2020).
Pajtler, K. W. et al. Nat. Commun. 10, 3914 (2019).
Bhat, P., Honson, D. & Guttman, M. Nat. Rev. Mol. Cell. Biol. 22, 653–670 (2021).
Pandya-Jones, A. et al. Nature 587, 145–151 (2020).
Boija, A. et al. Cell 175, 1842–1855 (2018).
Strom, A. R. et al. Nature 547, 241–245 (2017).
Cai, D. et al. Nat. Cell Biol. 21, 1578–1589 (2019).
Mohammad, F. et al. Nat. Med. 23, 483–492 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Dadras, M.S., Fine, H.A. Nuclear condensates in YAP1-driven ependymoma. Nat Cell Biol 25, 211–213 (2023). https://doi.org/10.1038/s41556-022-01081-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-022-01081-w
- Springer Nature Limited